Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...

詳細記述

書誌詳細

主要な著者:	Yuki Oda, Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
フォーマット:	Artigo
言語:	Inglês
出版事項:	Open Exploration Publishing Inc. 2026-04-01
シリーズ:	Exploration of Targeted Anti-tumor Therapy
主題:	bacillus calmette–guérin (bcg) therapy non-muscle invasive bladder cancer urinary immune profiling urinary microbiome dynamics firmicutes/bacteroidetes ratio progression-free survival
オンライン･アクセス:	https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!